Dr Reddys Reports First Profit Decline in Five Quarters While Beating Analyst Estimates
Dr Reddys Laboratories reported a 12.1 billion rupee profit for the third quarter. This 14.4 percent decline is the first in over a year but beat estimates.
Insights:
Dr. Reddy's Laboratories Ltd reported a consolidated net profit of 12.1 billion rupees for the third quarter ended December 31. Announced on January 21, 2026, the figure represents a 14.4 percent decline from the same period last year. This result marks the first quarterly profit fall for the drugmaker in five quarters, ending a streak of four consecutive quarters of profit growth prior to this reporting period.
Despite the year-over-year drop, the performance of Dr. Reddy's Laboratories Ltdsignificantly outpaced market expectations. Industry analysts had on average estimated that the profit for the company would fall to 10.70 billion rupees. The actual results exceeded this consensus estimate by 13 percent, demonstrating stronger operational resilience than anticipated by the financial community.
